The curious paradox in CVD

Getting to the heart of synthetic data

Mitigating the rare disease RWD deficit

The politics of vaccine replication and access

The animal testing argument

Cell and gene therapy: a victim of its own success

Artificially intelligent drug discovery

Ripples of change in R&D

Going the extra mile for women's health

Decentralised clinical trials: going green

Keeping the spark alive in vaccine development

Time to tackle AMR

Overcoming decentralised clinical trial obstacles

Resilience After Rejection

The Rare Disease Disparity

A Heyday for mRNA

A Fairer Framework for Drug Approvals

A Conversation on Clinical Trial Transformation

Streamlining R&D with 3D

Reaching the Virtual Summit